Results 41 to 50 of about 934,005 (172)

Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases

Journal of Ovarian Research, 2023
Background The indications for fertility preservation (FP) have expanded. A few patients who underwent gonadotoxic treatment did not have the opportunity to receive FP, leading to concerns that these patients may develop premature ovarian insufficiency ...
Saki Saito, Mitsutoshi Yamada, Rika Yano, Kazuko Takahashi, Akiko Ebara, Hiroe Sakanaka, Miho Matsumoto, Tomoko Ishimaru, Hiroki Utsuno, Yuichi Matsuzawa, Reina Ooka, Mio Fukuoka, Kazuhiro Akashi, Shintaro Kamijo, Toshio Hamatani, Mamoru Tanaka   +15 more
doaj   +1 more source

DataSheet_1_Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle.pdf

, 2022
A suggested explanation for the pituitary-suppressive effects of progestin-primed ovarian stimulation cycles (PPOS) is pituitary luteinizing hormone (LH) depletion with progestin exposure during the follicular phase.
Engin Turkgeldi (12036806), Ipek Keles (12036812), Erkan Kalafat (6207248), Sule Yıldız (12565774), Merve Dizdar (12036803), Baris Ata (5810324)   +5 more
core   +1 more source

Retrospective study of influencing factors on the outcomes of luteal phase stimulation in patients with dual stimulation [PDF]

PeerJ, 2023
Background Dual/double stimulation (DS) is an ovarian stimulation strategy that has emerged in recent years; it is characterized by two rounds of ovarian stimulation and oocyte retrieval in the same menstrual cycle.
Yuanyuan Chen, Hong Ye, Junhua Bao, Yanping Cai, Yuanbo Hu, Hongli Yan   +5 more
doaj   +2 more sources

DataSheet_2_Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle.pdf

, 2022
A suggested explanation for the pituitary-suppressive effects of progestin-primed ovarian stimulation cycles (PPOS) is pituitary luteinizing hormone (LH) depletion with progestin exposure during the follicular phase.
Engin Turkgeldi (12036806), Ipek Keles (12036812), Erkan Kalafat (6207248), Sule Yıldız (12565774), Merve Dizdar (12036803), Baris Ata (5810324)   +5 more
core   +1 more source

Efficacy of Progestin Primed Ovarian Stimulation versus GnRH Antagonist Protocols in Clomiphene Resistant PCOS Undergoing ICSI Cycles. Randomized Controlled Trial (RCT) aa [PDF]

Minia Journal of Medical Research
Background: Polycystic ovary syndrome (PCOS) is one of the endocrine disorders and anovulatory cycles of reproductive age women, it represents 70% of anovulation.
Mohamed Abdel Hameed, Ayman Abdel Megeed, Reham Taha, Manar Elsayed Amin   +3 more
doaj   +1 more source

Management of PCOS IVF Cycle

Fertility & Reproduction, 2023
PCOS is the most common Endocrine and Metabolic disorder in reproductive age women, being the most common cause of anovulatory Infertility. PCOS is a vicious circle of Insulin Resistance, Hyperandrogenism and improper LH secretions.
Duru Shah
doaj   +1 more source

Progestin-primed ovarian stimulation

Current Opinion in Obstetrics & Gynecology
Purpose of review The use of progestins as pituitary suppressors has increased progressively, along with more detailed indications for their use, thereby consolidating an alternative approach to the personalization of ovarian stimulation.
Giles, J, Cruz, F, Garcia-Velasco, JA
openaire   +4 more sources

The cumulative live birth rates of 18 593 women with progestin-primed ovarian stimulation-related protocols and frozen-thawed transfer cycles. [PDF]

Human Reproduction Open
Li Wang, Yali Liu, Wenya Guo
exaly   +2 more sources

A comparative analysis of progestin-primed ovarian stimulation versus GnRH antagonists protocols pertaining to stimulation parameters and embryological outcomes in patients with endometrioma. [PDF]

Front Endocrinol (Lausanne)
Research question: Do embryo parameters and live birth rates differ between patients with endometrioma undergoing a freeze-all strategy using either GnRH antagonists or progestin-primed ovarian stimulation (PPOS)?
Boynukalin FK, Tohma YA, Gultomruk M, Yarkiner Z, Akkaya CM, Ozkavukcu S, Bahceci M, Bozdağ G.   +7 more
europepmc   +2 more sources

Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: Comparing With Short Protocol

, 2022
Background: Many studies have demonstrated the positive clinical value of progestin-primed ovarian stimulation (PPOS) in patients with polycystic ovary syndrome (PCOS) who underwent assisted reproductive technology.
Kuang, Y, Si, J, Li, M, Yan, Z, Cai, R, Li, D, Jin, W, Wang, L, Chen, Q, Long, H, Chen, C, Lyu, Q, Yu, W, Yu, S, Hui Long, Yanping Kuang, Renfei Cai, Zhiguang Yan, Qiuju Chen, Jiqiang Si, Sha Yu, Menghui Li, Wei Jin, Dongying Li, Weina Yu, Chen Chen, Qifeng Lyu, Li Wang   +27 more
core   +1 more source